ID   OM-2
AC   CVCL_W942
SY   OM2
DR   CGH-DB; 362-2
DR   Cosmic; 930343
DR   Cosmic; 1046037
DR   Wikidata; Q54932005
RX   PubMed=17052259;
RX   PubMed=17599052;
CC   Population: Japanese.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 7
//
RX   PubMed=17599052; DOI=10.1038/sj.onc.1210589;
RA   Suzuki, Emina
RA   Imoto, Issei
RA   Pimkhaokham, Atiphan
RA   Nakagawa, Takayuki
RA   Kamata, Nobuyuki
RA   Kozaki, Ken-ichi
RA   Amagasa, Teruo
RA   Inazawa, Johji
RT   "PRTFDC1, a possible tumor-suppressor gene, is frequently silenced in
RT   oral squamous-cell carcinomas by aberrant promoter hypermethylation.";
RL   Oncogene 26:7921-7932(2007).
//
RX   PubMed=17052259; DOI=10.1111/j.1349-7006.2006.00343.x; PMCID=PMC11160012;
RA   Kozaki, Ken-ichi
RA   Imoto, Issei
RA   Pimkhaokham, Atiphan
RA   Hasegawa, Shogo
RA   Tsuda, Hitoshi
RA   Omura, Ken
RA   Inazawa, Johji
RT   "PIK3CA mutation is an oncogenic aberration at advanced stages of oral
RT   squamous cell carcinoma.";
RL   Cancer Sci. 97:1351-1358(2006).
//